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A b s t r a c t
Introduction: Endovascular revascularization (ER) techniques in patients with peripheral artery disease (PAD) have been devel-
oped and became more accessible in recent years. The ER is a first-line treatment in the majority of patients with symptomatic PAD. 
However, data on assessment of predictors of long-term outcomes of retrograde ER in patients with PAD are scarce.
Aim: To evaluate predictors of long-term outcomes of retrograde ER in patients with chronic total occlusion in lower limb ar-
teries.
Material and methods: We analyzed data of 834 patients who underwent retrograde ER. Baseline clinical characteristics and 
procedural data were collected. Patients were followed up for 36 months, and the primary endpoint was all-cause mortality.
Results: All patients were symptomatic and had failed antegrade ER. The procedural success rate was 92%. Cumulative all-cause 
mortality was 13.4% at 36-month follow-up. In multivariate analysis history of stroke, Rutherford category, chronic limb ischemia, 
chronic kidney disease (CKD), chronic obstructive pulmonary disease (COPD) and previous ER of other lesion were independent 
predictors of a higher mortality rate after 36 months (hazard ratio (HR) for stroke 2.4, 95% confidence interval (CI): 1.55–3.66; p = 
0.0002; HR for age per 10 years 1.37, 95% CI: 1.15–1.64; p = 0.0002; HR for Rutherford category 1.63, 95% CI: 1.35–1.98; p < 0.0001, 
HR for chronic limb ischemia 0.44, 95% CI: 0.25–0.8, p = 0.007; HR for CKD 1.73, 95% CI: 1.14–2.56, p = 0.01; HR for COPD 2.4, 
95% CI: 1.5–3.7, p = 0.0004; HR for previous ER 0.59, 95% CI: 0.35–0.94, p = 0.02).
Conclusions: History of stroke, Rutherford category, chronic limb ischemia, CKD, COPD, and previous ER of other lesion were 
independently associated with increased risk of all-cause death.
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S u m m a r y
The endovascular revascularization (ER) techniques in patients with peripheral artery disease (PAD) have been developed 
and became more accessible in recent years. However data on assessment of predictors of long-term outcomes of retrograde 
ER in patients with PAD are scarce. In the present study, we identified predictors of long-term outcomes including mortality 
in patients with PAD undergoing retrograde ER. Predictors of the composite endpoint (death, reER and amputation) were 
diabetes, history of stroke and Rutherford grade. Moreover, Rutherford grade, the presence of coronary artery disease and 
history of stroke were independent predictors of composite end point (death, reER, amputation, myocardial infarction, lower 
extremity bypass and thrombendaterectomy).
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Introduction
The prevalence of peripheral artery disease (PAD) in-
creases in the aging population and therefore represents 
a growing problem with diagnostics and management of 
patients affected by cardiac diseases sharing the same 
etiology and risk factors [1]. Endovascular revascular-
ization (ER) techniques in patients with PAD have been 
developed and became more accessible in recent years. 
The ER is a first-line treatment in the majority of patients 
with symptomatic PAD. In patients with chronic total 
occlusion (CTO) of the lower limb arteries and failure of 
antegrade ER, the retrograde access is a  treatment op-
tion before referral for vascular surgery or conservative 
treatment. Several studies estimating long-term results 
of antegrade ER have been published so far, including 
those comparing antegrade and retrograde access sites 
[2, 3]. However, data on assessment of predictors of long-
term outcomes of retrograde ER in patients with PAD are 
scarce. 
Aim
Thus, we aimed to evaluate predictors of long-term 




This study was a prospective, observational registry 
of 939 consecutive patients in two experienced academ-
ic centers, who underwent retrograde recanalization of 
CTO localized in the iliac artery, superficial femoral artery 
(SFA), popliteal artery (PA) or below the knee arteries af-
ter at least one unsuccessful antegrade attempt. Finally, 
data of 834 patients with available follow-up were an-
alyzed. Baseline clinical characteristics and procedural 
data were collected. 
Study endpoints
Patients were followed up for 36 months, and the 
primary endpoint was all-cause mortality. The secondary 
composite endpoint consisted of death, re-ER, and am-
putation. The tertiary composite endpoint consisted of 
death, re-ER, amputation, stroke, myocardial infarction, 
arterial bypass, and thromboendarterectomy. The study 
protocol conforms to the ethical guidelines of the 1975 
Declaration of Helsinki with later amendments and was 
approved by the institutional ethical board. All patients 
provided informed consent. 
Procedural characteristics
Antegrade failure was defined as an inability to wire 
the distal part of the vessel after the occlusion via the 
access site, located in the contralateral artery or proxi-
mal to the CTO lesion. According to the local protocol, pa-
tients were screened for concomitant diseases, risk fac-
tors, and medications. In all patients, the ankle-brachial 
index (ABI) was determined and severity of PAD was as-
sessed according to the Rutherford, Fontaine and Wagner 
scales before the procedure. The decision on the use of 
retrograde recanalization and access site was based on 
previous angiography. Retrograde recanalization was per-
formed under local anesthesia and required two access 
sites: antegrade and retrograde. Both proximal and distal 
punctures were done under the guidance of Doppler ul-
trasound and/or fluoroscopy. After crossing the occlusion 
with a wire through the retrograde approach, predilata-
tion with a balloon catheter was done. Stent implanta-
tion was left to the operator’s decision. After the proce-
dure, the distal sheet was removed immediately and the 
proximal sheet was maintained up to 4 h. In some cases, 
due to dissection, the balloon inflations were performed 
from both ante- and retrograde access (kissing balloons 
technique) to tear the dissection and facilitate the cap-
ture of the wire with a diagnostic catheter. 
Pharmacotherapy
As periprocedural treatment all patients received 
dual antiplatelet therapy: aspirin 75 mg permanently 
and clopidogrel 75 mg for 3 months, high dose of statin 
and according to the local protocol low-molecular-weight 
heparin for 4 weeks. Additional treatment was accordant 
to individual risk factors and comorbidities, including 
beta blockers, statins, and angiotensin-converting-en-
zyme inhibitors.
Statistical analysis
Categorical variables are presented as numbers and 
percentages. Continuous variables are expressed as mean 
± standard deviation or median and interquartile range. 
Normality was assessed with the Shapiro-Wilk test. 
Equality of variances was assessed using Levene’s test. 
Multivariable Cox regression analysis was performed to 
find significant predictors of mortality and outcomes and 
presented as hazard ratios (HR) with 95% confidence 
intervals (CI). All baseline characteristics and procedur-
al data were tested. Forward selection with a probabil-
ity value for covariates to enter the model was set at 
the 0.05 level. All tests were two-tailed, and a p-value of 
< 0.05 was considered statistically significant. All statis-
tical analyses were performed with JMP, Version 13.1.0 
(SAS Institute INC., Cary, NC, USA).
Results
A total of 939 consecutive patients with PAD requiring 
revascularization were enrolled between 2009 and 2015 
and then followed up. Of them, 834 patients were avail-
able for detailed analysis. All patients were symptomat-
ic and had failed antegrade ER. The median age was 68 
(60–76) years, and the majority of patients were male 
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(62.6%). Baseline clinical characteristics are presented 
in Table I. The procedural success rate was 92%. Angio-
graphic and procedural data are shown in Table II. Study 
endpoints are presented in Figure 1. Cumulative all-cause 
Table I. Baseline clinical characteristics (n = 834)
Variable All
Age, median (IQR) [years] 68.0 (60.0–76.0)
Men 522 (62.6%)
Body mass index, median (IQR) [kg/m2] 27.0 (23.71–30.1)
Arterial hypertension 735 (88.2%)
Diabetes mellitus 342 (49.1%)
Chronic kidney disease 135 (16.2%)
Chronic obstructive pulmonary disease 98 (11.8%)
Coronary artery disease 339 (40.7%)
Hyperlipidemia 708 (84.9%)
History of stroke/transient ischemic attack 74 (8.9%)
Smoking 463 (55.6%)
Previous endovascular revascularization of 
other lesion
183 (22.0%)
Previous arterial bypass 89 (10.7%)


















Acute limb ischemia 42 (5%)
Chronic limb ischemia 468 (56.1%)
Intermittent claudication < 50 m 322 (39%)
Ankle brachial index, median (IQR) 0.6 (0.3–0.7)











Iliac artery – chronic total occlusion 105 (12.6%)
Deep femoral artery – significant lesion 42 (5%)
Common femoral artery:














Lesion length [mm] 127.9 ±110.3
Popliteal artery:
Lesion length [mm] 52.3 ±48.7
Chronic total occlusion 99 (11.9%)
Tibio-fibular trunk:
Significant lesion 206 (24.7%)
Chronic total occlusion 82 (9.8%)
Tibialis anterior artery:
Significant lesion 387 (46.5%)
Chronic total occlusion 30 (3.6%)
Peroneal artery – significant lesion 305 (36.6%)
Tibialis posterior artery:
Significant lesion 391 (47.5%)
Chronic total occlusion 70 (8.4%)
Fluoroscopy time [s] 825.1 ±697.4
Contrast volume [ml] 120.9 ±84.5
Time from procedure to discharge [days] 3.3 ±2.1
Hospitalization time [days] 5.5 ±5.2
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mortality was 13.4% at 36 months. In multivariate anal-
ysis history of stroke, Rutherford category, chronic limb 
ischemia, chronic kidney disease (CKD), chronic obstruc-
tive pulmonary disease (COPD) and previous ER of other 
lesion were independent predictors of a higher mortality 
rate after 36 months (HR for stroke 2.4, 95% confidence 
interval (CI): 1.55–3.66; p = 0.0002; HR for age per 10 
years 1.37, 95% CI: 1.15–1.64; p = 0.0002; HR for Ruther-
ford category 1.63, 95% CI: 1.35–1.98; p < 0.0001, HR for 
chronic limb ischemia 0.44, 95% CI: 0.25–0.8, p = 0.007; 
HR for CKD 1.73, 95% CI: 1.14–2.56, p = 0.01; HR for 
COPD 2.4, 95% CI: 1.5–3.7, p = 0.0004; HR for previous 
ER 0.59, 95% CI: 0.35–0.94, p = 0.02). Predictors of sec-
ondary endpoint (death, reER and amputation) were dia-
betes (HR = 1.3, 95% CI: 1.07–1.55, p < 0.0075), Ruther-
ford category (HR = 1.27, 95% CI: 1.18–1.37, p < 0.0001) 
and history of stroke (HR = 1.41, 95% CI: 1.05–1.86, 
p = 0.02), all age-adjusted. Rutherford grade (HR = 1.21, 
95% CI: 1.13–1.3, p < 0.0001), coronary artery disease 
(HR = 1.4, 95% CI: 1.16–1.67, p = 0.0003) and history of 
stroke (HR = 1.38, 95% CI: 1.03–1.81, p = 0.02) were in-
dependent predictors of the tertiary composite end point 
(death, reER, amputation, myocardial infarction, lower 
extremity bypass and thromboendarterectomy). Figure 2 
presents all-cause mortality during 36 months of follow-up.
Discussion
In the present study, we identified predictors of long-
term outcomes including mortality in patients with PAD 
undergoing retrograde ER. Predictors of the composite 
endpoint (death, reER and amputation) were diabetes, 
history of stroke and Rutherford grade. Moreover, Ruth-
erford grade, the presence of coronary artery disease 
and history of stroke were independent predictors of 
composite end point (death, reER, amputation, myocar-
dial infarction, lower extremity bypass and thromboend-
arterectomy). The ER in PAD treatment has become more 
accessible and developed in recent years, even in its ret-
rograde technique. Retrograde technique is an interven-
tional option of choice after antegrade attempt failure, 
especially in high-risk patients who are not suitable can-
didates for surgical treatment. Importantly, the results of 
percutaneous angioplasty from the retrograde approach 
in PAD patients have improved significantly since initial 
reports [2, 4–7]. Montero-Baker et al. reported that the 
failure rate of antegrade recanalization can reach up to 
20% in CTO lesions in lower limb arteries [8]. Difficulties 
in crossing the occlusion are related to the morphology 
of the plaque as CTOs are harder, more fibrous within 
the proximal cap, and with diffuse calcification [9–11]. 
For retrograde puncture, there are a few arteries that can 
be chosen: the distal segment of the SFA, PA, tibial ar-
tery, and pedal artery. The procedure is performed under 
fluoroscopy or ultrasound guidance to avoid additional 
bleeding complications and damage of the punctured 
artery. SFA-CTO prevalence reaches around 50% in symp-
tomatic patients with PAD [12]. Nevertheless, there are 
still scarce data on large populations that estimate the 
predictors of long-term treatment results in this group 
of patients, especially those treated from the retro-
grade approach. In the current study, the mortality after 
36 months of follow-up was 13.4%, which was relatively 
low compared to previous publications, where mortality 
in the overall group of patients with PAD treated with en-
dovascular interventions reached 6–50% with a similar 
mean age of participants to the current study at baseline 
and depended on the length of follow-up [13–15]. How-
ever, compared to previous studies, the rate of CKD was 
lower, impacting the mortality. Additionally, the patients 
were strictly oriented towards drug compliance and ad-
ministration of the drugs was monitored during every 
follow-up visit. In another study assessing effectiveness 
and outcomes after pedal vascular access in critical limb 
ischemia mortality was 23% during the mean follow-up 
of 17 months [16]. A systematic review with more than 
1500 patients reported that the 1-year survival rate in 
patients treated with subintimal recanalization depend-
ed on the location of the culprit artery or symptoms be-
fore angioplasty and ranged between 65% and 78% in 
patients with critical limb ischemia and crural lesions, 
and between 86% and 100% in those with mixed dis-
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Figure 2. Kaplan-Meier survival curve for patients 
undergoing retrograde endovascular revascular-
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ease and femoral lesions [17]. The study published by 
Kim et al. reported 1-year mortality following subintimal 
angioplasty in patients with more advanced and dis-
seminated atherosclerosis (TASC C and D) at 5.5% [18]. 
In contrast, in some studies performed in patients with 
critical or subcritical lower limb ischemia the mortality 
rate after 5 years of follow-up reached almost 50% [15]. 
History of stroke and previous ER of another lesion were 
also associated with increased mortality risk. However, 
there are no data available so far regarding this prob-
lem. Rutherford category represents the grade of clini-
cal symptoms which are directly affected by the extent 
of lower limb artery atherosclerosis. The culprit lesion 
length, clinical state before angioplasty, and the degree 
of dissemination of atherosclerotic lesions (TASC stage) 
are among confirmed predictors of clinical outcomes in 
patients with PAD treated with endovascular interven-
tions [15]. The study published by Murata et al. including 
1088 patients, comprising 1306 limbs with critical isch-
emia treated with endovascular therapy, confirmed the 
previously discovered relationship in patients with CAD 
treated with percutaneous intervention [19]. Also, one of 
several factors for which there is a  strong relationship 
with endovascular outcomes in the follow-up period is 
CKD. The CKD was found to be a predictor of increased 
mortality after 4 years of follow-up in patients with PAD 
treated with ER, and it was strictly correlated with the 
stage of CKD. The projected 4-year mortality in patients 
with known CKD was 27%, while in patients with other 
stages it was 46% (stage 2), 52% (stage 3), 72% (stage 4) 
and 78% (stage 5) [20]. In a study by Willenberg et al. the 
presence of CKD was an independent predictor of higher 
mortality in patients with chronic limb ischemia under-
going ER [21]. Among the most influential mechanisms 
responsible for worse outcomes after ER of lower limb ar-
teries we can distinguish prothrombotic state related to 
COPD, elevated proinflammatory markers and markers of 
oxidative stress [22, 23]. The relationship between COPD 
and future cardiovascular adverse events in patients 
with CAD has repeatedly been demonstrated so far [24, 
25]. Diabetes mellitus is a well-established risk factor for 
poor outcomes in cardiovascular diseases. In a study by 
Neupane et al. with 714 patients, diabetes mellitus was 
independently associated with higher mortality, major 
amputations and repeat revascularization at 5 years [26].
Study limitations
Only patients with available long-term follow-up were 
enrolled in the current analysis. Due to drop-offs, the 
baseline risk characteristics and mortality rates might be 
underestimated. 
Conclusions
History of stroke, Rutherford category, chronic limb 
ischemia, CKD, COPD, and previous ER of other lesion 
were independently associated with increased risk of 
long-term all-cause death.
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